Category - Feature

Feature

BioLight Life Sciences focusing on ophthalmic portfolio

BioLight Life Sciences Investments (OTCQX:BLGTY; TASE:BOLT) is now defining itself as an ophthalmology company after spending several years assembling a cluster of investments in the sector as well as in cancer...

December 8, 2015

Feature

Oramed sees value creating events through 2016

By Len Zehr Oramed Pharmaceuticals’ (NASDAQ:ORMP) oral insulin development program has multiple value-creating events in the works through 2016. They include completion of an ongoing Phase 2b FDA multi-site study for...

December 1, 2015

Feature

ReVENT Medical prepares for U.S. pivotal trial in sleep apnea

By Len Zehr Closely-held ReVENT Medical expects to begin a U.S. pivotal trial in the first half next year with its minimally invasive surgical solution to treat obstructive sleep apnea (OSA). “OSA is the most common...

November 24, 2015

Feature

Concert starts multiple dose trial with CF drug

By Len Zehr Concert Pharmaceuticals (NASDAQ:CNCE), which is modifying known drugs with its deuterium technology, last week initiated a multiple ascending dose Phase 1 trial with healthy volunteers of its next generation...

November 17, 2015

Feature

Viking Therapeutics to complete two POC trials in 2016

By Len Zehr Viking has successfully completed three Phase 1 studies with VK5211, including a 21-day ascending dose study. Viking Therapeutics (NASDAQ:VKTX) expects to complete two proof-of-concept Phase 2 trials in 2016...

November 10, 2015

Feature

Kadimastem plans stem cell therapy trial for ALS in late 2016

By Len Zehr Kadimastem (TASE:KDST) hopes its pre-IND meeting with the FDA in November will outline a protocol for a Phase 1/2a clinical trial of its stem cell therapy for the treatment for Amyotrophic Lateral Sclerosis...

November 3, 2015

Feature

CRH Medical to consolidate GI anesthesia market

By Len Zehr With four acquisitions and a joint venture under its belt over the past 10 months, CRH Medical (NYSE MKT:CRHM; TSX:CRH) is in talks to continue consolidating the large and fragmented market of...

October 27, 2015

Feature

In conversation with Arun Menawat

As president and CEO of Novadaq Technologies (NASDAQ:NVDQ; TSX:NDQ), Arun Menawat has led the company through a strategic transformation this year into a direct sales company from one originally dependent on partners to...

October 20, 2015

Feature

Titan Pharma advancing pipeline in PD, other disorders

By Len Zehr Titan Pharmaceuticals (NASDAQ:TTNP), which is awaiting an FDA approval decision for its six-month Probuphine implant to treat opioid dependence, is advancing its ProNeura implant technology against...

October 13, 2015

Feature

Clerio Vision developing non-invasive laser vision correction

By Len Zehr Closely-held Clerio Vision hopes to begin proof-of-concept studies next year of a non-invasive, incision-less and tissue sparing vision correction laser technology that modifies the refractive index of the...

October 6, 2015

Category - Feature

Subscribe